Please login to the form below
Sylvant
This page shows the latest Sylvant news and features for those working in and with pharma, biotech and healthcare.
EC approves Janssen rare blood disorder drug
EC approves Janssen rare blood disorder drug. Sylvant available to treat multicentric Castleman's disease. ... The European Commission's decision to greenlight Sylvant comes shortly after its April.
Latest news
-
FDA approves Janssen drug for rare Castleman’s disease
FDA approves Janssen drug for rare Castleman’ s disease. Sylvant approved to treat lymphoma-like condition. ... Sylvant is also under review in the EU where Janssen submitted a drug filing in September last year. .
-
EMA backs Janssen rare disease drug for approval
EMA backs Janssen rare disease drug for approval. Castleman's disease treatment Sylvant wins CHMP recommendation. ... J&J subsidiary Janssen-Cilag's Castleman's disease treatment Sylvant (situximab) has been recommended for approval in Europe.
-
Boehringer/Lilly's empagliflozin among CHMP recommendations
There were also recommendations for four orphan drugs: Janssen-Cilag's Sylvant (situximab) and, along with the companion diagnostic drugs Folcepri (etarfolatide) and Neocepri (folic acid), Endocyte's Vynfinit (vintafolide).
More from news
Approximately 2 fully matching, plus 2 partially matching documents found.
Featured jobs
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
-
Associate Medical Director
-
Highly Competitive
- Senior Account Executive, London, Medical Communications
-
Excellent package
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
-
Account Director
-
£48, 000 - £60, 000
-
Medical/ Scientific Director
-
Salary TBC
- Director, Market Access / HEOR - North-West
-
Negotiable
-
New Business Director - PR
-
Competitive Salary and benefits
-
Senior Medical Writer
-
Competitive Salary
- Account Manager, Healthcare Public Affairs
-
£32, 000 – £40, 000 benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Senior Medical Writer
-
Great salary and benefits
Subscribe to our email news alerts
- Herpes Labialis Treatment Market is anticipated to expand at a CAGR of 4.6% over 2017-2027
- Molecular Biology Enzymes, Kits & Reagents Market worldwide are poised to exceed US$ 21,000 Mn in revenues by 2026-end.
- Anaesthesia Machines Market: A Billion Dollar Increase in Sales Revenue During 2017 - 2027
- Female Pelvic Implants Market is expected to reach a value of over US$ 300 Mn by the end of 2027
- Vulvodynia Treatment Market is expected to register a CAGR of 6.1% over the forecast period of 2018 and 2028
- 3D Printed Medical Devices Market is expected to expand at a CAGR of 18.1% during the forecast period 2017–2027
PMHub
Random42 Scientific Communication
Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...
Latest intelligence
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
- World Diabetes Day: Interaction and impact of diabetes on mental health
- For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
- Innovation in merger control and the impact on the pharmaceutical sector
- Is focusing on pipeline products enough to assess regulatory risks?...
Quick links
Infographics
